Cannabis Bioscience International Holdings, Inc. (CBIH) Income from Continuing Operations (2022 - 2026)

Cannabis Bioscience International Holdings has reported Income from Continuing Operations for 5 years, with the latest figure at 104035.0 in Q1 2026.

• Quarterly Income from Continuing Operations rose 31.42% year-over-year to 104035.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 699980.0 (down 81.97% YoY) and the FY2025 annual result came in at 557627.0, up 12.92% from the prior year.
• Income from Continuing Operations climbed to 104035.0 in Q1 2026 per CBIH's latest filing, from 113737.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 64202.0 in Q2 2024 and troughed at 324655.0 in Q1 2023.
• A 5-year average of 173299.36 and a median of 166748.0 in 2023 frame the typical range for Income from Continuing Operations.
• The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations soared 77.2% in 2024, then tumbled 322.36% in 2025.
• Over 5 years, Income from Continuing Operations stood at 219886.0 in 2022, then surged by 43.41% to 124428.0 in 2023, then jumped by 45.09% to 68328.0 in 2024, then slumped by 66.46% to 113737.0 in 2025, then rose by 8.53% to 104035.0 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 104035.0, 113737.0, and 211046.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.